http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2606605-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93e8f3f0e161df3d09d4b9a837a21e23
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
filingDate 2011-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee550c749fae842dcb419632c4c10901
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e39876c26529a05a7a3e7c298a4fa82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f004247cad48882e5311999c8027c2a
publicationDate 2017-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2606605-T3
titleOfInvention BVDV vaccine
abstract Combined vaccine for the protection of susceptible ruminants against BVDV, characterized in that the vaccine comprises a first BVDV belonging to a first type and carries an E2 gene of BVDV of said first type, a second BVDV belonging to a first type, in that the BVDV E2 gene belonging to said first type is replaced by the BVDV E2 gene belonging to a second type, and a pharmaceutically acceptable vehicle, and in which said first BVDV and said second BVDV have the same structure.
priorityDate 2010-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP25477
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64006
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71597907
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428438886

Total number of triples: 35.